Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients

R Bellmann, P Smuszkiewicz - Infection, 2017 - Springer
Introduction Because of the high mortality of invasive fungal infections (IFIs), appropriate
exposure to antifungals appears to be crucial for therapeutic efficacy and safety. Materials …

Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents

GC de Oliveira Santos, CC Vasconcelos… - Frontiers in …, 2018 - frontiersin.org
The Candida genus comprises opportunistic fungi that can become pathogenic when the
immune system of the host fails. Candida albicans is the most important and prevalent …

Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents

C Spampinato, D Leonardi - BioMed research international, 2013 - Wiley Online Library
The genus Candida includes about 200 different species, but only a few species are human
opportunistic pathogens and cause infections when the host becomes debilitated or …

[PDF][PDF] Triazole antifungals: a review

LR Peyton, S Gallagher, M Hashemzadeh - Drugs Today, 2015 - researchgate.net
Invasive fungal infections and systemic mycosis, whether from nosocomial infection or
immunodeficiency, have been on an upward trend for numerous years. Despite …

Antifungal drugs: the current armamentarium and development of new agents

N Robbins, GD Wright, LE Cowen - Microbiology spectrum, 2016 - Am Soc Microbiol
Invasive fungal infections are becoming an increasingly important cause of human mortality
and morbidity, particularly for immunocompromised populations. The fungal pathogens …

Natural products to drugs: natural product-derived compounds in clinical trials

MS Butler - Natural product reports, 2008 - pubs.rsc.org
Covering: 2005 to 2007 Natural product and natural product-derived compounds that are
being evaluated in clinical trials or are in registration (as at 31st December 2007) have been …

Efflux-mediated antifungal drug resistance

RD Cannon, E Lamping, AR Holmes… - Clinical microbiology …, 2009 - Am Soc Microbiol
Fungi cause serious infections in the immunocompromised and debilitated, and the
incidence of invasive mycoses has increased significantly over the last 3 decades. Slow …

Azole antifungals: 35 years of invasive fungal infection management

D Allen, D Wilson, R Drew, J Perfect - Expert review of anti-infective …, 2015 - Taylor & Francis
Prior to 1981, treatment options for invasive fungal infections were limited and associated
with significant toxicities. The introduction of ketoconazole marked the beginning of an era of …

Clinical hepatotoxicity associated with antifungal agents

I Kyriakidis, A Tragiannidis, S Munchen… - Expert opinion on drug …, 2017 - Taylor & Francis
ABSTRACT Introduction: Invasive fungal diseases (IFDs) are a leading cause of morbidity
and mortality among immunocompromised patients with bone marrow failure syndromes …

Onychomycosis

O Welsh, L Vera-Cabrera, E Welsh - Clinics in dermatology, 2010 - Elsevier
Onychomycosis is a frequent nail disease caused by dermatophytes, yeasts, and
nondermatophyte molds. Trichophyton rubrum, T mentagrophytes, and Epidermophyton …